Global Ischemic Heart Disease Market - Industry Analysis Size Share Growth Trends and Forecast 2024 - 2031

Product Description

Ischemic heart disease, also known as CHD (coronary heart diseases) and CAD (coronary artery disease) is caused by defect and damage in the heart. Silent ischemia is one of the most prevailing ischemic diseases across the globe, caused by heart attack without prior warning. Moreover, the people having previous heart attacks or have diabetes are more prone to silent ischemia. Unhealthy dietary habits such as excessive consumption of alcohol & tobacco and lack of exercise increase the risk of ischemic heart diseases around the globe. The Ischemic Heart Disease market revenue was xx Million USD in 2019, grew to xx Million USD in 2023, and will reach xx Million USD in 2031, with a CAGR of xx during 2024-2031. Considering the influence of COVID-19 on the global Ischemic Heart Disease market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions. This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery. Under COVID-19 Outbreak, how the Ischemic Heart Disease Industry will develop is also analyzed in detail in Chapter 1.8 of this report. Major Players in Ischemic Heart Disease market are: Sanofi SA Cardinal Health, Inc. General Electric Co. Stryker Corp. Genentech, Inc. Abbott Laboratories Daiichi Sankyo Co. Ltd. Lepu Medical Technology (Beijing) Co., Ltd. AstraZeneca PLC Bayer AG Siemens Healthcare Pvt. Ltd. Koninklijke Philips N.V. W. L. Gore & Associates, Inc. Edwards Lifesciences Corp. Medtronic, PLC Boston Scientific Corp. Merck KGaA Meril Life Science Pvt. Ltd. TERUMO CORP. Amgen Inc. Most important types of Ischemic Heart Disease products covered in this report are: Angina Myocardial Infarction Ischemic Stroke Most widely used downstream fields of Ischemic Heart Disease market covered in this report are: Drug Discovery Companies Medical Equipment Companies Investment Firms Government Organizations Major Regions or countries covered in this report: North America Europe China Japan Middle East and Africa South America India South Korea Southeast Asia Others In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations. In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out. In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.